• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在骨肉瘤治疗中,失巢凋亡和肿瘤免疫微环境相关基因的预后价值。

Prognositic value of anoikis and tumor immune microenvironment-related gene in the treatment of osteosarcoma.

机构信息

Department of Spine Surgery, Third Xiangya Hospital, Central South University, Changsha 410013.

Shanghai Key Laboratory of Regulatory Biology; Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai 200241, China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 May 28;49(5):758-774. doi: 10.11817/j.issn.1672-7347.2024.230519.

DOI:10.11817/j.issn.1672-7347.2024.230519
PMID:39174890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11341232/
Abstract

OBJECTIVES

Osteosarcoma is a highly aggressive primary malignant bone tumor commonly seen in children and adolescents, with a poor prognosis. Anchorage-dependent cell death (anoikis) has been proven to be indispensable in tumor metastasis, regulating the migration and adhesion of tumor cells at the primary site. However, as a type of programmed cell death, anoikis is rarely studied in osteosarcoma, especially in the tumor immune microenvironment. This study aims to clarify prognostic value of anoikis and tumor immune microenvironment-related gene in the treatment of osteosarcoma.

METHODS

Anoikis-related genes (ANRGs) were obtained from GeneCards. Clinical information and ANRGs expression profiles of osteosarcoma patients were sourced from the therapeutically applicable research to generate effective therapies and Gene Expression Omnibus (GEO) databases. ANRGs highly associated with tumor immune microenvironment were identified by the estimate package and the weighted gene coexpression network analysis (WGCNA) algorithm. Machine learning algorithms were performed to construct long-term survival predictive strategy, each sample was divided into high-risk and low-risk subgroups, which was further verified in the GEO cohort. Finally, based on single-cell RNA-seq from the GEO database, analysis was done on the function of signature genes in the osteosarcoma tumor microenvironment.

RESULTS

A total of 51 hub ANRGs closely associated with the tumor microenvironment were identified, from which 3 genes (, , ) were selected to construct the prognostic model. Significant differences in immune cell activation and immune-related signaling pathways were observed between the high-risk and low-risk groups based on tumor microenvironment analysis (all <0.05). Additionally, characteristic genes within the osteosarcoma microenvironment were identified in regulation of intercellular crosstalk through the GAS6-MERTK signaling pathway.

CONCLUSIONS

The prognostic model based on ANRGs and tumor microenvironment demonstrate good predictive power and provide more personalized treatment options for patients with osteosarcoma.

摘要

目的

骨肉瘤是一种常见于儿童和青少年的高度侵袭性原发性恶性骨肿瘤,预后较差。锚定依赖性细胞死亡(失巢凋亡)已被证明在肿瘤转移中不可或缺,调节肿瘤细胞在原发部位的迁移和黏附。然而,作为一种程序性细胞死亡,失巢凋亡在骨肉瘤中很少被研究,特别是在肿瘤免疫微环境中。本研究旨在阐明失巢凋亡和肿瘤免疫微环境相关基因在骨肉瘤治疗中的预后价值。

方法

从 GeneCards 中获取与失巢凋亡相关的基因(ANRGs)。从治疗性应用研究生成有效的治疗方法和基因表达综合数据库(GEO)中获取骨肉瘤患者的临床信息和 ANRGs 表达谱。通过估计包和加权基因共表达网络分析(WGCNA)算法鉴定与肿瘤免疫微环境高度相关的 ANRGs。采用机器学习算法构建长期生存预测策略,将每个样本分为高危和低危亚组,在 GEO 队列中进一步验证。最后,基于 GEO 数据库中的单细胞 RNA-seq,分析特征基因在骨肉瘤肿瘤微环境中的功能。

结果

共鉴定出 51 个与肿瘤微环境密切相关的核心 ANRGs,从中选择 3 个基因(、、)构建预后模型。基于肿瘤微环境分析,高危组和低危组之间在免疫细胞激活和免疫相关信号通路方面存在显著差异(均<0.05)。此外,通过 GAS6-MERTK 信号通路调节细胞间串扰,鉴定出骨肉瘤微环境中的特征基因。

结论

基于 ANRGs 和肿瘤微环境的预后模型具有良好的预测能力,为骨肉瘤患者提供了更个性化的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/7de944b40986/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/0f1372be1674/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/44aa04568a89/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/c33f4e83d839/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/3df87c612be7/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/5f4923af8ced/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/504758ac99bb/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/d1a5aef2905c/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/76f6979d9b67/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/b01440101257/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/7de944b40986/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/0f1372be1674/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/44aa04568a89/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/c33f4e83d839/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/3df87c612be7/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/5f4923af8ced/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/504758ac99bb/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/d1a5aef2905c/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/76f6979d9b67/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/b01440101257/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/675f/11341232/7de944b40986/ZhongNanDaXueXueBaoYiXueBan-49-5-758-g010.jpg

相似文献

1
Prognositic value of anoikis and tumor immune microenvironment-related gene in the treatment of osteosarcoma.在骨肉瘤治疗中,失巢凋亡和肿瘤免疫微环境相关基因的预后价值。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 May 28;49(5):758-774. doi: 10.11817/j.issn.1672-7347.2024.230519.
2
Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.失巢凋亡模式在骨肉瘤中呈现出不同的预后和免疫格局。
Int Immunopharmacol. 2023 Feb;115:109684. doi: 10.1016/j.intimp.2023.109684. Epub 2023 Jan 9.
3
Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes.开发一种新型标志物预测骨肉瘤患者的生存并影响其免疫微环境:与失巢凋亡相关的基因。
J Immunol Res. 2024 Mar 27;2024:6595252. doi: 10.1155/2024/6595252. eCollection 2024.
4
A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration.一个新型的与失巢凋亡相关的基因标志物可预测乳腺癌患者的预后,并揭示免疫浸润情况。
Medicine (Baltimore). 2023 Oct 27;102(43):e35732. doi: 10.1097/MD.0000000000035732.
5
System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy.基于凋亡相关基因的系统分析鉴定 MAPK1 为新辅助化疗骨肉瘤的治疗靶点。
BMC Musculoskelet Disord. 2024 Jun 4;25(1):437. doi: 10.1186/s12891-024-07547-2.
6
A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.基于缺氧基因的signature 预测儿童骨肉瘤的生存并影响肿瘤免疫微环境。
J Immunol Res. 2021 Jul 15;2021:5523832. doi: 10.1155/2021/5523832. eCollection 2021.
7
The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.肿瘤免疫微环境和免疫相关特征可预测骨肉瘤患者的化疗反应。
BMC Cancer. 2021 May 21;21(1):581. doi: 10.1186/s12885-021-08328-z.
8
A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.基于失巢凋亡相关基因的新型分层框架预测骨肉瘤患者的预后。
Front Immunol. 2023 Jul 27;14:1199869. doi: 10.3389/fimmu.2023.1199869. eCollection 2023.
9
Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.骨肉瘤患者预后肿瘤微环境相关基因的综合分析。
BMC Cancer. 2020 Aug 27;20(1):814. doi: 10.1186/s12885-020-07216-2.
10
Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.识别和验证与凋亡相关的基因特征作为一种新的宫颈癌、宫颈内膜腺癌的预后模型,并揭示免疫浸润。
Medicina (Kaunas). 2023 Feb 13;59(2):358. doi: 10.3390/medicina59020358.

本文引用的文献

1
Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis.针对肿瘤和骨微环境:骨转移去势抵抗性前列腺癌患者的新治疗机会。
Biochim Biophys Acta Rev Cancer. 2024 Jan;1879(1):189033. doi: 10.1016/j.bbcan.2023.189033. Epub 2023 Nov 29.
2
Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment.纳米药物递送系统靶向肿瘤微环境:治疗黑色素瘤的有前景策略。
Cancer Lett. 2023 Oct 10;574:216397. doi: 10.1016/j.canlet.2023.216397. Epub 2023 Sep 18.
3
CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis.
CD47 连接重定位抑制性受体 SIRPA 以抑制整合素激活和吞噬作用。
Immunity. 2023 Sep 12;56(9):2172. doi: 10.1016/j.immuni.2023.08.003.
4
Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance.外泌体环状 RNA:癌症化疗耐药的罪魁祸首。
Drug Resist Updat. 2023 Mar;67:100937. doi: 10.1016/j.drup.2023.100937. Epub 2023 Feb 2.
5
Integration of single-cell and bulk transcriptomics reveals immune-related signatures in keloid.单细胞和 bulk 转录组学的整合揭示了瘢痕疙瘩中的免疫相关特征。
J Cosmet Dermatol. 2023 Jun;22(6):1893-1905. doi: 10.1111/jocd.15649. Epub 2023 Jan 26.
6
Improved visualization of high-dimensional data using the distance-of-distance transformation.使用距离-距离变换改进高维数据的可视化。
PLoS Comput Biol. 2022 Dec 20;18(12):e1010764. doi: 10.1371/journal.pcbi.1010764. eCollection 2022 Dec.
7
Osteosarcoma-Derived Exosomes as Potential PET Imaging Nanocarriers for Lung Metastasis.骨肉瘤来源的外泌体作为肺转移潜在的正电子发射断层显像(PET)成像纳米载体
Small. 2022 Dec;18(49):e2203999. doi: 10.1002/smll.202203999. Epub 2022 Oct 31.
8
Systemic vaccination induces CD8 T cells and remodels the tumor microenvironment.全身免疫接种可诱导 CD8 T 细胞并重塑肿瘤微环境。
Cell. 2022 Nov 10;185(23):4317-4332.e15. doi: 10.1016/j.cell.2022.10.006. Epub 2022 Oct 26.
9
Clinical implications of T cell exhaustion for cancer immunotherapy.T 细胞耗竭对癌症免疫治疗的临床意义。
Nat Rev Clin Oncol. 2022 Dec;19(12):775-790. doi: 10.1038/s41571-022-00689-z. Epub 2022 Oct 10.
10
Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance.循环肿瘤细胞与血细胞的串扰:生物学和临床相关性。
Cell Rep. 2022 Aug 30;40(9):111298. doi: 10.1016/j.celrep.2022.111298.